Dignity Talk: Helping Palliative Care Patients and Families Have Important Conversations

NCT ID: NCT01883375

Last Updated: 2017-12-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

56 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-03-31

Study Completion Date

2017-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Dying patients and their families face many challenges near the end-of-life. Not only do patients often experience physical distress, but they also have feelings of loss of dignity, isolation, and uncertainty. Family members also face many challenges. They bear witness to the suffering of loved ones, and they face uncertainty, loss, and at times a mounting sense of helplessness.

The purpose of this study is to introduce and evaluate a new intervention called Dignity Talk, meant to enhance end-of-life experience for both patients and their families. Dignity Talk is based on a set of questions by which terminally ill patients and their family members can engage in meaningful conversations with each other. It is intended to lessen feelings of loss and helplessness and enhance feelings of connectedness by facilitating conversations that tap into a sense of meaning and purpose, sharing of memories, wishes, hopes, and giving guidance to those who will soon be left behind.

In Phase 1, 20 patients and family members will help finalize the method and Dignity Talk question framework (is it easy to understand, do the investigators have the right questions, and is the wording sensitive). In Phase 2 of the study the investigators will ask 100 patient-family pairs for feedback about Dignity Talk: what influence it had on their palliative care experience, whether it works well, and whether this intervention should become a regular part of palliative care. The investigators will also ask for feedback from health-care providers in both phases. We are requesting approval for an amendment to the healthcare provider feedback focus group questions. Will add those documents when they are approved.

Four to six months after the death of their loved one, the investigators will contact the family member to ask their thoughts about Dignity Talk, how it shaped their experience of their grief and bereavement.

The investigators expect that the study will show that Dignity Talk can be an effective, highly accessible palliative care intervention, which will enhance the end-of-life experience for palliative patients and the families who support them.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

See above summary

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Palliative Care Family End of Life Care

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Palliative Care Family adaptation, psychological

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Dignity Talk dyad completers

Those dyads where both patient and family member co-participant complete the protocol using the Dignity Talk Communication Topics

Group Type EXPERIMENTAL

Dignity Talk

Intervention Type BEHAVIORAL

Patient and family member participants will be given the Dignity Talk framework questions and asked to use them in conversation with each other. Research nurse will return at day 4-6 to confirm both participants have covered all items they wish to discuss. 4-6 months after the death of patient, family members will be contacted in order to collect data pertaining to their bereavement experiences and distress. Will also be asked to complete evaluative feedback on Dignity Talk.

Dignity Talk non-completers

Those dyads where patient and family member co-participant either do not complete the protocol or do not use the Dignity Talk Communication Topics (November 2016 - the investigators have not as yet enrolled any participants who have not completed the study without using the Dignity Talk Topics. However some participants have withdrawn from the study without completing.

Group Type EXPERIMENTAL

The Dignity Talk Communication Topics

Intervention Type BEHAVIORAL

There have not been any non-completers - this arm not being used currently

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Dignity Talk

Patient and family member participants will be given the Dignity Talk framework questions and asked to use them in conversation with each other. Research nurse will return at day 4-6 to confirm both participants have covered all items they wish to discuss. 4-6 months after the death of patient, family members will be contacted in order to collect data pertaining to their bereavement experiences and distress. Will also be asked to complete evaluative feedback on Dignity Talk.

Intervention Type BEHAVIORAL

The Dignity Talk Communication Topics

There have not been any non-completers - this arm not being used currently

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

For Patient:

Patients being cared for:

* in a palliative care unit or whose care is focused on palliation as determined by clinical staff
* or patients who have have a confirmed diagnosis of amyotropic lateral sclerosis, and have symptoms in a domain that interferes with their social or occupation functioning: a) mobility, b) dysphasia, c) dyspnea, or d) speech or patients who have are have been on dialysis \> 3 months and are \> 60 years of age - or residents of Personal Care Home all of whom are:
* 18 years of age or older
* able to provide informed oral and written consent
* cognitive capacity (based on clinical consensus)

For Family Member or Close Friend:

* Family member or close friend who the patient identifies they would be comfortable talking with using the Dignity Talk question framework
* Family member who is 18 years of age or older
* Family member who is able to provide oral and written consent
* Family member who has cognitive capacity to participate in meaningful conversation (based on research staff decision)

For Healthcare Provider:

* Employed one of the participating sites
* in a discipline directly involved in clinical care (physician, nursing, social work, spiritual care, allied healthcare, etc.)
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

Sponsor Role collaborator

University of Manitoba

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Victoria Hospice

Victoria, British Columbia, Canada

Site Status

St. Boniface Hospital

Winnipeg, Manitoba, Canada

Site Status

Riverview Health Centre

Winnipeg, Manitoba, Canada

Site Status

Concordia Hospital

Winnipeg, Manitoba, Canada

Site Status

Deer Lodge Centre

Winnipeg, Manitoba, Canada

Site Status

Grace Hospital

Winnipeg, Manitoba, Canada

Site Status

Health Sciences Centre

Winnipeg, Manitoba, Canada

Site Status

Manitoba Renal Program

Winnipeg, Manitoba, Canada

Site Status

Seven Oaks Hospital

Winnipeg, Manitoba, Canada

Site Status

Victoria Hospital

Winnipeg, Manitoba, Canada

Site Status

Winnipeg Regional Health Authority

Winnipeg, Manitoba, Canada

Site Status

WRHA Personal Care Homes

Winnipeg, Manitoba, Canada

Site Status

Dr. Bob Kemp Hospice

Hamilton, Ontario, Canada

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Canada

References

Explore related publications, articles, or registry entries linked to this study.

Guo Q, Chochinov HM, McClement S, Thompson G, Hack T. Development and evaluation of the Dignity Talk question framework for palliative patients and their families: A mixed-methods study. Palliat Med. 2018 Jan;32(1):195-205. doi: 10.1177/0269216317734696. Epub 2017 Nov 13.

Reference Type DERIVED
PMID: 29130367 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

H2013:024

Identifier Type: -

Identifier Source: org_study_id